Related Articles
Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions.
Pleurectomy, intrapleural cisplatin and interferon followed by systemic carboplatin plus interferon in malignant pleural mesothelioma
EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy
Optimal therapy of malignant pleural effusions
Effect of hydrothorax EGFR gene mutation and EGFR‑TKI targeted therapy on advanced non‑small cell lung cancer patients